The University of Alabama at Birmingham
The University of Alabama at Birmingham
Birmingham, Alabama, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic macular edema, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, retinal disorder, vascular disorder | Not yet recruiting | Phase 1 | 2025-10-03 | NCT06881888 |